BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gouravani M, Khalili N, Razi S, Keshavarz-Fathi M, Khalili N, Rezaei N. The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers. Expert Rev Clin Immunol 2020;16:175-87. [PMID: 31928260 DOI: 10.1080/1744666X.2020.1713755] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang M, Wang X, Wang P, Peng W, Zhang B, Guo L. Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action. Mol Med Rep 2020;22:3255-62. [PMID: 32945430 DOI: 10.3892/mmr.2020.11422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ju M, Bi J, Wei Q, Jiang L, Guan Q, Zhang M, Song X, Chen T, Fan J, Li X, Wei M, Zhao L. Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer. Brief Bioinform 2021;22:bbaa345. [PMID: 33212483 DOI: 10.1093/bib/bbaa345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
3 Li Y, Lv J, Shi W, Feng J, Liu M, Gan S, Wu H, Fan W, Shi M. Inflammasome Signaling: A Novel Paradigm of Hub Platform in Innate Immunity for Cancer Immunology and Immunotherapy. Front Immunol 2021;12:710110. [PMID: 34421915 DOI: 10.3389/fimmu.2021.710110] [Reference Citation Analysis]
4 Gumpinger AC, Lage K, Horn H, Borgwardt K. Prediction of cancer driver genes through network-based moment propagation of mutation scores. Bioinformatics 2020;36:i508-15. [PMID: 32657361 DOI: 10.1093/bioinformatics/btaa452] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
5 Urwanisch L, Luciano M, Horejs-Hoeck J. The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia. Int J Mol Sci 2021;22:1271. [PMID: 33525345 DOI: 10.3390/ijms22031271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Liu Y, Fu J, Ning X, Li H, Ma X, Wang K, Bian W, Zhang Y, Yu G, Li Z. Malignancy Risk of Immunoglobin G4-Related Disease: Evidence from a Large Cohort Multicenter Retrospective Study. Rheumatol Ther 2021;8:1207-21. [PMID: 34184190 DOI: 10.1007/s40744-021-00326-8] [Reference Citation Analysis]
7 Yang L, Hu M, Lu Y, Han S, Wang J. Inflammasomes and the Maintenance of Hematopoietic Homeostasis: New Perspectives and Opportunities. Molecules 2021;26:E309. [PMID: 33435298 DOI: 10.3390/molecules26020309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Longhitano L, Li Volti G, Giallongo C, Spampinato M, Barbagallo I, Di Rosa M, Romano A, Avola R, Tibullo D, Palumbo GA. The Role of Inflammation and Inflammasome in Myeloproliferative Disease. J Clin Med 2020;9:E2334. [PMID: 32707883 DOI: 10.3390/jcm9082334] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]